sábado, 14 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 22, 2026

Top Analyst Reports for Exxon Mobil, IBM & Citigroup

View original at finance.yahoo.com
Top Analyst Reports for Exxon Mobil, IBM & Citigroup Wednesday, April 22, 2026 The Zacks Research Daily presents the best research output of our analyst team…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • IBM's growth is likely to be driven primarily by analytics, cloud computing, and security in the long haul

    60% confidence
  • IBM's watsonx platform is gaining significant market traction

    60% confidence
  • Citigroup's ongoing transformation initiatives will likely support revenue growth as stranded costs and transformation spend begin to moderate

    60% confidence
  • Citigroup management expects revenues to see a 4-5% compound annual growth rate (CAGR) through 2026

    60% confidence
  • Exxon Mobil has raised its dividend every year for the past 43 years

    60% confidence
  • Exxon Mobil is constructing the world's largest low-carbon hydrogen and ammonia plant in Baytown

    60% confidence
  • Exxon Mobil intends production in the Permian to surpass 2.5 million oil-equivalent barrels per day beyond 2030

    60% confidence
  • Oil-Dri Corporation earnings remain sensitive to customer concentration, channel volatility, and external disruptions

    60% confidence
  • Natural Resource Partners' cash flow resilience is reliant on commodity recovery

    60% confidence

Data points we hold from this source

Exxon Mobil Corporation · dividend increase streak43 years
Exxon Mobil Corporation · upstream earnings growth100 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Top Analyst Reports for Exxon Mobil, IBM & Citigroup — Source | Via News | es.VIA.NEWS